Sernova Biotherapeutics Inc
SEOVF
$0.1422
$0.01249.55%
OTC PK
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.13% | -7.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.52% | -34.35% | |||
| Operating Income | 1.52% | 34.35% | |||
| Income Before Tax | -10.18% | 33.99% | |||
| Income Tax Expenses | -11.76% | -- | |||
| Earnings from Continuing Operations | -10.14% | 33.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.14% | 33.90% | |||
| EBIT | 1.52% | 34.35% | |||
| EBITDA | -0.47% | 35.10% | |||
| EPS Basic | -6.09% | 36.46% | |||
| Normalized Basic EPS | -5.56% | 36.28% | |||
| EPS Diluted | -6.09% | 36.46% | |||
| Normalized Diluted EPS | -5.56% | 36.28% | |||
| Average Basic Shares Outstanding | 3.15% | 4.58% | |||
| Average Diluted Shares Outstanding | 3.15% | 4.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||